Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05049889

Screening for Individual Susceptibility Factors to Immersion Pulmonary Edema

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
63 (estimated)
Sponsor
Direction Centrale du Service de Santé des Armées · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

Immersion Pulmonary Edema (IPE) is a relatively new form of hemodynamic pulmonary edema. The number of cases has been increasing over the last ten years and it has become the second most common cause of hospitalization for military divers, after decompression sickness. The pathophysiological mechanisms of IPE are not completely known. Its occurrence is linked to a combination of factors related to the environmental constraints of diving, as well as to the diver's equipment. The main external factors are increased hydrostatic pressure, cold, intense effort and emotional stress. The impact of internal factors is not known. At this time, no severe forms of IPE have been identified in the military. However, it is important to identify this pathology at an early stage, even if the signs appear minor, because the continuation of underwater activity can significantly worsen the clinical picture. The risk of recurrence (greater than 15%) could result in a severe or even lethal accident.

Conditions

Interventions

TypeNameDescription
OTHERTerrestrial exerciseAt visit 1 (Day 0), an exercise test will be performed (maximal incremental test), followed by a 30-minute submaximal exercise at constant load. During this exercise, continuous data collection will be performed: * Continuous 12-lead electrocardiogram * Continuous monitoring of blood pressure and ventilation.
OTHERSwimming exerciseAt visit 2 (Day 7), the subjects will perform a swimming exercise in the experimental pool equipped with a turbine to create a counter-current. The water speed will be constant (4 min per 100 m, i.e. 1.5 km/h). The duration of the exercise will be 30 minutes. Each diver will breathe with the help of a snorkel. During this exercise, continuous data collection will be performed: * Continuous 12-lead electrocardiogram * Continuous monitoring of blood pressure and ventilation.
DEVICETransthoracic cardiac ultrasoundThe participants will have a transthoracic cardiac ultrasound to measure the dilatations of the cardiac cavities at visit 1 and 2.
DEVICETransthoracic pulmonary ultrasoundThe participants will have a transthoracic pulmonary ultrasound to quantify the presence of signs of pulmonary vascular overload (comet tails) at visit 1 and 2.
BIOLOGICALBlood collectionSeveral blood samples will be collected at visit 1 and 2.

Timeline

Start date
2022-08-17
Primary completion
2026-08-01
Completion
2026-08-01
First posted
2021-09-20
Last updated
2022-09-14

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT05049889. Inclusion in this directory is not an endorsement.